retatrutide effects clinical trial retatrutide Weight Loss Treatment Explained New GLP-3 drug significantly slashes

Though Retatrutide is not yet FDA-approved, its potential effectiveness shows great promise, as evidenced by the TRIUMPH-1 Phase 3 trials that demonstrated up to 28.3% weight loss over 80 weeks

Who should not take Akkermansia

Watch 2: Foundayo and the Oral GLP-1 Race The second watch point is Foundayo

Semaglutide and Tirzepatide are available by prescription through Health Canada, though coverage varies by province and insurance plan

Dual GIP and GLP-1 receptor agonist Tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes

Just like their injectable counterparts, these pills help regulate blood sugar and suppress appetite, leading to weight loss and improved glucose control